{"id":"W2794108628","doi":"10.1158/1538-7445.sabcs17-ot3-05-03","title":"Abstract OT3-05-03: POLARIS: Palbociclib (P) in hormone receptor-positive (HR+) advanced breast cancer: A prospective multicenter noninterventional study","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine; Breast cancer; Tolerability; Oncology; Population; Palbociclib; Cancer; Clinical trial; Metastatic breast cancer; Gynecology; Adverse effect","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001036057,0.0004294564,0.0006769784,0.0005701129,0.0003477227,0.00008206369,0.0004266511,0.000170972,0.00275381],"category_scores_gemma":[0.0001240644,0.0003896176,0.0001832379,0.001305244,0.0008733867,0.0005655017,0.0002680137,0.001492909,0.0002849627],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003255925,"about_ca_system_score_gemma":0.0008144802,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004196627,"about_ca_topic_score_gemma":0.004200084,"domain_scores_codex":[0.9951447,0.0002760702,0.0006636622,0.001174665,0.001450219,0.001290635],"domain_scores_gemma":[0.9967347,0.0001584444,0.0001910647,0.0006323466,0.001891263,0.0003921235],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.04572619,0.005774747,0.6158477,0.0002850836,0.001377403,0.0003424377,0.01491273,0.00003552816,0.1569738,0.0001321699,0.002384843,0.1562073],"study_design_scores_gemma":[0.01474272,0.002095862,0.9620239,0.001393865,0.00004793368,0.00003747609,0.005426253,0.00003036551,0.01118581,0.0001562175,0.002440537,0.0004190156],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.985454,0.005007068,0.00003537925,0.003476982,0.0004687288,0.003691653,0.0005796696,0.0001109329,0.001175541],"genre_scores_gemma":[0.9935881,0.000446516,0.0003053325,0.0002227512,0.001292356,0.002477944,0.00003042962,0.0001249263,0.001511586],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3461762,"threshold_uncertainty_score":0.9998556,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03918688413333515,"score_gpt":0.4267827817146972,"score_spread":0.3875958975813621,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}